Kevin A. Maupin

Glycogene Expression Alterations Associated with Pancreatic Cancer Epithelial-Mesenchymal Transition in Complementary Model Systems

Kevin A. Maupin, Arkadeep Sinha, Emily Eugster et al. · PLoS ONE · 2010 · 114 citations · Full text

The fine specificity of mannose-binding and galactose-binding lectins revealed using outlier motif analysis of glycan array data

Kevin A. Maupin, D. Liden, Brian B. Haab · Glycobiology · 2011 · 86 citations · Full text

Galactose-binding Lectins, Glycobiology, Molecular Biology +21

Enhanced Discrimination of Malignant from Benign Pancreatic Disease by Measuring the CA 19-9 Antigen on Specific Protein Carriers

Tingting Yue, Kevin A. Maupin, Brian P. Fallon et al. · PLoS ONE · 2011 · 75 citations · Full text

Specific Protein Carriers, Oncology, Pancreatic Cancer +15

Identification of blood‐protein carriers of the CA 19‐9 antigen and characterization of prevalence in pancreatic diseases

Tingting Yue, Katie Partyka, Kevin A. Maupin et al. · PROTEOMICS · 2011 · 65 citations · Full text

Pancreatic Diseases, Prognostic Biomarkers, Pancreatic Cancer +15

Diverse monoclonal antibodies against the <scp>CA</scp> 19‐9 antigen show variation in binding specificity with consequences for clinical interpretation

Katie Partyka, Kevin A. Maupin, Randall E. Brand et al. · PROTEOMICS · 2012 · 57 citations · Full text

Clinical Immunology, Immunocytochemical Technique, Clinical Interpretation +19